Wegovy Pen - Weight Loss Injection

Wegovy is a prescription medication approved for weight loss in the UK. It contains semaglutide, a compound that can help reduce appetite and promote a feeling of fullness.

Wegovy has been approved for weight loss and weight management in the UK. However, you need to meet eligibility criteria and obtain a prescription in order to buy Wegovy in the UK as it is not available over the counter.

Semaglutide, the active ingredient in Wegovy pens of all strengths, is in a category of medications called GLP-1 receptor agonists. In short, GLP-1 medications mimic a natural hormone that makes you feel fuller for longer, experience fewer cravings, and ultimately consume fewer calories.

Wegovy is intended to be used alongside a healthy, balanced diet and increased physical activity. This combination has been shown to lead to significant weight loss in many research trials, as well as in the real world over the last few years. At Habitual we've helped thousands of patients achieve and sustain weight loss through the use of Wegovy and our app-based behavioural coaching.

Wegovy is administered with a gradual dosage escalation over a 16-week period. Patients start with a 0.25mg once-weekly dose for the initial 4 weeks, progressively advancing until they reach the maintenance dose of 2.4 mg once weekly starting from week 17 onwards. This incremental adjustment is crucial as it mitigates the likelihood of side effects. If any side effects occur, they are predominantly encountered during the dose-escalation phase and typically reduce over time

The key difference between Wegovy and Mounjaro lies in their composition. Wegovy contains a compound called semaglutide, whereas Mounjaro contains tirzepatide.
‍
Both semaglutide and tirzepatide fall under the category of GLP-1 (glucagon-like peptide-1) analogs. GLP-1s imitate incretin, a natural gut hormone released post-meal. This imitation brings about various effects, such as appetite suppression, prolonged feelings of fullness, and a decrease in the perceived pleasure of eating. These qualities have made them popular choices for effective weight loss medications.
‍
Now, here's where Mounjaro sets itself apart. While Wegovy contains only GLP-1s, Mounjaro (and tirzepatide) includes both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP). GIP adds extra benefits, such as reducing fat accumulation, boosting bone formation, increasing glucagon production, and decreasing stomach acid secretion.

As with all medications, it's crucial to be aware of potential side effects before commencing a new medication.The most frequently reported side effects include:
‍
- Nausea
- Diarrhea
- Decreased appetite
- Vomiting
- Constipation
- Indigestion
- Stomach Pain
‍
If you find these side effects difficult to manage, it's important to inform your prescriber and consider discontinuing treatment. Although Wegovy is generally considered very safe, individual reactions can vary.
‍
Side effects of Wegovy are often more noticeable with dosage increases but typically diminish within a few days. Should you experience unexpected or challenging side effects, please consult your GP for guidance on the best course of action.

Wegovy is prescribed as a weight-loss treatment for individuals with a BMI over 30 or a BMI over 27 with weight-related conditions such as high blood pressure. It is recommended for use in conjunction with a calorie-restricted diet and increased physical exercise to support weight loss.

Wegovy is unsuitable for:

- Women who are pregnant or breastfeeding; treatment should be ceased at least two months before attempting to conceive.
- Individuals with BMIs outside the suitable range.
- Those taking specific medications.Individuals with a history of certain conditions, such as pancreatitis.
- Those with type 1 diabetes.Individuals who have previously discontinued GLP-1 treatment due to side effects.

Please be aware that this list is not exhaustive, and each patient should undergo an individual assessment by a licensed prescriber.

This medicine should not be used during pregnancy. It is strongly recommended to use contraception while on this medication. If you are planning to become pregnant, it is advised to discontinue this medication at least two months before attempting to conceive. In the event of pregnancy, suspicion of pregnancy, or plans to conceive while using this medication, it is crucial to promptly consult with your doctor, as the treatment may need to be halted.

Additionally, this medication should not be used while breastfeeding, as its passage into breast milk is uncertain.

For optimal effectiveness, it is advisable to complement your prescription with a nutritious diet and consistent exercise. Include lots of lean proteins, healthy fats, non-starchy vegetables, and high-fibre carbohydrates. Aim to restrict the intake of sugary foods, fried items, refined carbohydrates, and alcohol.

Wegovy can be purchased online, in the UK but it is not available over-the-counter. You will need to go through a reputable healthcare provider and meet NICE eligibility criteria to obtain a prescription. Your healthcare provider will conduct an online assessment and decide the most suitable treatment plan for you, which may or may not include a Wegovy prescription. This process can be completed online, and if you qualify, you can purchase your program via the internet